Leukotriene B4

未知生产厂商

Leukotriene B4 has been used in trials studying the treatment of HIV Infections.

生成 AI 研报

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Leukotriene B4 has been used in trials studying the treatment of HIV Infections.

技术标识符

化学式: C₂₀H₃₂O₄
CAS 编号: 71160-24-2
UNII ID: 1HGW4DR56D

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Use of inhibitors of leukotriene B4 receptor BLT2 for treating asthma
- US 8906632 B2
  申请人: KIM JAE-HONG优先权: 2011
  US
  6 件公开
- US 2010034835 A1
  申请人: UNIV IND & ACAD COLLABORATION优先权: 2008
  US
Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use related applications
US 2002119977 A1申请人: KHANAPURE SUBHASH P优先权: 2001
US
5 件公开
Methods for inhibiting proliferation and inducing apoptosis of cancer cells
CN 1237968 C申请人: UNIV CREIGHTON优先权: 2000
CN
WO
3 件公开
Stabilized leukotriene B4 (LTB4) agent pharmaceutical formulation
US 8664271 B2申请人: BORGEAT PIERRE优先权: 2005
CN
US
3 件公开
Crystalline leukotriene B4
US 8426469 B2申请人: HORVATH KAROL优先权: 2006
EP
US
3 件公开
Leukotriene B4 binding soluble lipocalin receptor from ixodes ricinus
US 8324161 B2申请人: GODFROID EDMOND优先权: 2007
EP
US
3 件公开
Leukotriene B4 inhibitors
- US 8093385 B2
  申请人: DOMINIQUE ROMYR优先权: 2008
  CN
  US
  3 件公开
- US 7989454 B2
  申请人: HOFFMANN LA ROCHE优先权: 2008
  CN
  US
  3 件公开
- US 8093253 B2
  申请人: DOMINIQUE ROMYR优先权: 2009
  CN
  US
  3 件公开
- US 8088936 B2
  申请人: DOMINIQUE ROMYR优先权: 2010
  CN
  US
  3 件公开
HETEROCYCLIC COMPOUNDS AS BLT2 AGONISTS AND THEIR MEDICAL USE
EP 4545138 A1申请人: FRAUNHOFER GES FORSCHUNG优先权: 2023
EP
WO
3 件公开
Leukotriene B4 receptor transgenic mice
US 6271435 B1申请人: BRIGHAM & WOMENS HOSPITAL优先权: 2000
US
3 件公开
Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor, a leukotriene B4 receptor inhibitor and a cyclosporin
US 7141599 B2申请人: PHARMACIA CORP优先权: 2000
US
3 件公开

药物

Leukotriene B4

概览

专利

Use of inhibitors of leukotriene B4 receptor BLT2 for treating asthma

Leukotriene B4 inhibitors